Crosstalk along the gut-liver axis modulates glutathione and cadmium-induced hepatotoxicity

Area of Science:

• Natural product chemistry
• Hepatology
• Oncology

Background:

• Hepatocellular carcinoma (HCC) and chronic liver disease pose significant health challenges.
• Current treatments for HCC and liver disease have limitations and side effects.
• The natural flavonoid morin is being investigated for its therapeutic potential.

Purpose of the Study:

• To evaluate the dual-function therapeutic potential of morin against hepatocellular carcinoma (HCC) and chronic liver disease.
• To investigate morin's mechanisms in counteracting liver injury and enhancing anti-cancer drug efficacy.
• To assess morin's ability to mitigate chemotherapy-induced nephrotoxicity.

Main Methods:

• Preclinical studies were conducted to assess morin's effects on toxin-induced liver injury.
• Investigated morin's impact on oxidative stress and inflammatory pathways (Nrf2/HO-1, NF-κB).
• Assessed morin's effect on cisplatin efficacy in HCC models, including autophagy and DNA repair modulation (PARP1).

Main Results:

• Morin demonstrated protective effects against toxin-induced liver injury by modulating oxidative stress and inflammation.
• In HCC models, morin enhanced cisplatin efficacy by suppressing PARP1-mediated autophagy and DNA repair.
• Morin concurrently reduced the nephrotoxic side effects associated with cisplatin treatment.

Conclusions:

• Morin exhibits dual therapeutic potential for both chronic liver disease and hepatocellular carcinoma.
• Morin's ability to protect normal tissues while enhancing anti-cancer effects makes it a promising candidate.
• Further clinical validation and improved delivery systems are necessary for morin's therapeutic application.